A Add to watchlist
$119.77 0.62 (-0.51%)
After Hours: $119.77 +0.00 (+0.00%)
Last updated: Apr 15, 2026 22:49
52-Week Range
$119.77
$99.12 $119.77 $160.27

Fundamentals Overview

Agilent Technologies, Inc. is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 26.4 PEG 10.71 P/B 4.91 P/S 4.79

Intrinsic value (DCF)

-34.2% downside vs price

Profitability

Net margin 18.3%

Risk (Beta)

1.3 — higher vol

Earnings & growth

EPS $4.54 Rev -3.4% Profit -29.7% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 58% confidence Risk: High Volatility — Beta 1.3. Consider smaller position size due to higher beta.

Supporting (Buy):

Analyst grade: B+ · Sentiment improving (3 upgrades)

Pressures (Sell):

DCF 34.2% downside vs price · 3M vs S&P 500: -19.8% · 3M vs Healthcare sector: -13%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$33.88B
P/E (TTM)
26.37
EPS (TTM)
$4.54
Dividend Yield
0.84%
52-Week Range
$99.12 - $160.27
Volume vs Avg
N/A
Beta
1.3

About

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission ...
Sector: Healthcare
Headquarters: US
Employees: 17,900
IPO Date: Nov 1999
Beta: 1.3 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 6, Equal Weight: 4, In Line: 4, Neutral: 2, Outperform: 4, Overweight: 10.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $78.81; current price is $119.77. That’s a -34.2% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 26.37
DCF value (model) $78.81 (-34.2% vs price)
PEG (TTM) 10.71
P/B (TTM) 4.91
P/S (TTM) 4.79
P/FCF (TTM) 34.11
Liquidity & enterprise
Current Ratio (TTM) 2.07
Quick Ratio (TTM) 1.59
Cash Ratio (TTM) 0.79
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 18.26%
Gross margin (TTM) 52.23%
Operating margin (TTM) 20.61%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for A.

Analyst Sentiment at a Glance

B+ Sentiment Improving
Buy 6Equal Weight 4In Line 4Neutral 2Outperform 4Overweight 10
3 upgrades, 0 downgrades
Price Target Consensus
Current $119.77
Median $167.50
Consensus $166.00
Low consensus $140.00
High consensus $180.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Evercore ISI Group maintain Outperform Outperform 2026-04-06
Morgan Stanley maintain Overweight Overweight 2026-03-03
Wells Fargo maintain Overweight Overweight 2026-02-26
TD Cowen maintain Buy Buy 2026-02-26
UBS maintain Buy Buy 2026-02-26
Barclays maintain Overweight Overweight 2026-02-26
Evercore ISI Group upgrade In Line Outperform 2026-01-05
Barclays upgrade Equal Weight Overweight 2025-12-15
Baird maintain Outperform Outperform 2025-11-25
Citigroup maintain Buy Buy 2025-11-25
Barclays maintain Equal Weight Equal Weight 2025-11-25
B of A Securities maintain Neutral Neutral 2025-11-25
Wells Fargo maintain Overweight Overweight 2025-11-25
JP Morgan maintain Overweight Overweight 2025-11-25
UBS maintain Buy Buy 2025-11-25
TD Cowen maintain Buy Buy 2025-10-14
JP Morgan maintain Overweight Overweight 2025-10-09
UBS upgrade Neutral Buy 2025-10-08
Evercore ISI Group maintain In Line In Line 2025-10-07
Barclays maintain Equal Weight Equal Weight 2025-10-02
Wells Fargo maintain Overweight Overweight 2025-09-15
Barclays maintain Equal Weight Equal Weight 2025-08-29
Evercore ISI Group maintain In Line In Line 2025-08-28
Wells Fargo maintain Overweight Overweight 2025-08-28
Baird maintain Outperform Outperform 2025-08-28
Evercore ISI Group maintain In Line In Line 2025-07-08
Evercore ISI Group maintain In Line In Line 2025-06-24
Barclays maintain Equal Weight Equal Weight 2025-06-24
UBS maintain Neutral Neutral 2025-05-29
JP Morgan maintain Overweight Overweight 2025-05-29